- Anbio Biotechnology Limited
Anbio Biotechnology Limited
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$5.00
1,600,000
Positive
High
3.7%
Offering Team
Deal Managers
- AC Sunshine Securities
Lawyers
- Ortoli Rosenstadt LLP
Auditors
- YCM CPA INC
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portf More
Deal Tracker
Investors
Filing
31 Dec, 2024Offer
19 Feb, 2025Look Ahead
Lock Up Expiry
19 Aug, 2025Earning
Nov 1, 2018IPO Terms
| Offer Price | $5.00 |
| Offer Size | 1M |
